Therapeutic agents for treatment of ocular hypertension

Details for Australian Patent Application No. 2011209685 (hide)

Owner Allergan, Inc.

Inventors Old, David W.; Gac, Todd S.

Agent Davies Collison Cave

Pub. Number AU-A-2011209685

PCT Pub. Number WO2011/094231

Priority 61/298,428 26.01.10 US

Filing date 25 January 2011

Wipo publication date 4 August 2011

International Classifications

C07D 333/40 Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

A61K 31/381 - having five-membered rings

A61P 27/06 Drugs for disorders of the senses

Event Publications

16 August 2012 PCT application entered the National Phase

  PCT publication WO2011/094231 Priority application(s): WO2011/094231

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011209699-A new method for secure user and transaction authentication and risk management

2011209676-Universal test strip port